Vanta Bioscience Ltd.

The trailing twelve month (TTM) PB ratio of Vanta Bioscience Ltd. is 1.15 as of June 21, 2025. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

Vanta Bioscience Ltd. reported an ROE of -14.16% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Vanta Bioscience Ltd., Promoter held 69.4%, and the public held 30.6% of the total shares.

You can easily buy shares of Vanta Bioscience Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

The fair value of Vanta Bioscience Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.